Open AccessPharmacokinetics of caspofungin in ICU patients
Author(s) -
Eline W. Muilwijk,
Jeroen Schouten,
Henk J. van Leeuwen,
Arthur R. H. van Zanten,
Dylan W. de Lange,
Angela Colbers,
Paul E. Verweij,
David M. Burger,
Peter Pickkers,
Roger J. M. Brüggemann
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku313
Subject(s) - cmin , caspofungin , cmax , pharmacokinetics , medicine , gastroenterology , pharmacology , amphotericin b , antifungal , dermatology
Caspofungin is used for treatment of invasive fungal infections. As the pharmacokinetics (PK) of antimicrobial agents in critically ill patients can be highly variable, we set out to explore caspofungin PK in ICU patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom